By submitting this form you agree to be contacted by KirkendallDwyer.com affiliates and/or attorneys regarding your claim. You consent to KirkendallDwyer.com contacting you through the use of text message, phone call, and electronic mail message even if your number is a wireless number or if I am presently listed on a Do Not Call list. My consent does not require purchase.
Today Johnson & Johnson settled five of its lawsuits claiming that its antipsychotic drug Risperdal caused boys to grow breast tissue. The hearing took place in Philadelphia, but the terms of the settlements were not disclosed.
The settlement of these cases comes on the heels of J&J’s efforts to keep former FDA chief David Kessler from taking the stand to testify about the drug company’s illegal promotion of the drug to children. Plaintiffs’ attorneys allege that J&J hid evidence that the drug caused hormonal changes that could trigger breast development in boys, and trained its pharmaceutical representatives to downplay this information in its doctors’ visits.
Despite denying this information and claiming that this breast development was a normal party of puberty, J&J settled these five bellwether cases.